Orchid Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

381.68

296.24

339.53

217.45

227.57

Operating profit

45.84

30.27

45.37

11.89

39.71

Interest

9.34

17.06

11.24

20.77

26.92

Gross profit

46.57

21.98

38.24

-3.99

15.00

EPS (Rs)

6.12

-4.27

-2.64

1.46

-5.01

Other income

10.07

8.77

4.11

4.89

2.20

Stock adjustment

-1.87

-55.01

14.30

-37.03

-35.22

Raw material

236.27

225.13

180.06

156.74

125.39

Power and fuel

-

-

-

-

-

Employee expenses

33.41

32.31

29.98

30.22

36.40

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

68.02

63.54

69.81

55.62

61.29

Provisions made

-

-

-

-

-

Depreciation

15.55

39.39

46.85

40.17

59.58

Taxation

-

-

-

-

-

Net profit / loss

31.02

-17.41

-10.77

5.97

-44.59

Extra ordinary item

-

-

-2.16

50.13

-

Prior year adjustments

-

-

-

-

-

Equity capital

50.72

40.82

40.82

40.82

88.96

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

12.01

10.22

13.36

5.47

17.45

GPM (%)

11.89

7.21

11.13

-1.80

6.53

NPM (%)

7.92

-5.71

-3.14

2.68

-19.41